Vivos (RDGL) Cash from Operations (2010 - 2025)
Vivos (RDGL) reported Cash from Operations of 539554.0 for Q4 2025, down 14.58% on a YoY basis from 631621.68 in Q4 2024, and down 17.68% sequentially from 458481.0 in Q3 2025.
Vivos (RDGL) Cash from Operations (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Cash from Operations data on file, last reported at 539554.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations fell 14.58% year-over-year to 539554.0; the trailing twelve-month figure through Dec 2025 stood at 2057743.0 (down 22.19% YoY), and the FY2025 full-year result was 2057743.0, down 22.19% from the prior year.
- Cash from Operations retreated to 539554.0 in Q4 2025, from 458481.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 171119.0 in Q2 2022 to a low of 604510.0 in Q2 2025.
- A 5-year average of 355934.1 and a median of 349317.0 in 2021 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations slumped 132.78% in 2021 and jumped 50.71% in 2022, its largest moves.
- Tracing RDGL's Cash from Operations over 5 years: stood at 235468.0 in 2021, then declined by 19.62% to 281667.0 in 2022, then tumbled by 64.43% to 463137.0 in 2023, then declined by 1.68% to 470912.0 in 2024, then decreased by 14.58% to 539554.0 in 2025.
- Business Quant data shows RDGL's Cash from Operations at 539554.0 in Q4 2025, 458481.0 in Q3 2025, and 604510.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | 43.80 Mn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | 290.00 Mn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 525.60 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 220.10 Mn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | -539,554.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -539,554.00 |
| Dec 31, 2025 | -539,554.00 |
| Sep 30, 2025 | -458,481.00 |
| Sep 30, 2025 | -458,481.00 |
| Jun 30, 2025 | -604,510.00 |
| Jun 30, 2025 | -604,510.00 |
| Mar 31, 2025 | -455,198.00 |
| Mar 31, 2025 | -455,198.00 |
| Dec 31, 2024 | -470,912.00 |
| Dec 31, 2024 | -470,912.00 |
| Sep 30, 2024 | -506,257.00 |
| Sep 30, 2024 | -506,257.00 |
| Jun 30, 2024 | -355,412.00 |
| Jun 30, 2024 | -355,412.00 |
| Mar 31, 2024 | -351,458.00 |
| Mar 31, 2024 | -351,458.00 |
| Dec 31, 2023 | -463,137.00 |
| Dec 31, 2023 | -463,137.00 |
| Sep 30, 2023 | -221,923.00 |
| Sep 30, 2023 | -221,923.00 |